Clinical Trial

Real-time Motion Management During Prostate and Lung Radiotherapy

Study acronym: REMIND
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this interventional non-inferiority trial is to assess the accuracy of different real-time motion management radiotherapy techniques. The main question the study aims to answer are: * What are the target margins for radiotherapy with motion management that are not inferior to target margin without motion management * What are the dosimetric and geometrical accuracy to patient for the motion management techniques. Participants will answer QoL questionary, and the accuracy of treatment will be assessed from treatment data.
Protocol Amendment History 3 changes
critical Trial status changed: Enrolling by Invitation → Active, Not Recruiting 2026-07-29
notable Primary completion pushed: 2026-05 -> 2027-06 2026-07-29
minor Completion pushed: 2026-12 -> 2027-12 2026-07-29
Trial Details
NCT Number NCT05844761
Lead Sponsor Region Skane
Conditions Cancer of Lung, Lung Metastasis, Cancer of Prostate
Enrollment 132 participants
Start Date 2023-05-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-28